Precision Performance Status Compared With ECOG Performance Status

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

41 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-11-22

Study Completion Date

2026-05-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study compares consumer movement trackers to the Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) in monitoring cancer patient movement. The ECOG PS emphasizes a patient's ambulatory status (ability to walk around), and scores patients on a scale of 0-5: 0 (no restrictions), 1 (ambulatory), 2 (\< 50% of hours spent in bed, unable to carry out work activities), 3 (\> 50% of hours spent in bed, limited in self care), 4 (bedbound and gravely disabled) and 5 (deceased). Accurate assessment of a patient's PS is paramount in informing therapeutic decision-making, whether it be to predict response and tolerability to treatment or determine eligibility for clinical trials. However, the ECOG PS scale is observational, and therefore limited in its precision. Information gained in this study may help researchers learn if there is a better way to assess patient movement with computerized analysis tools using movement trackers.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Movement and Fitness Trackers in Determining Performance Status

NCT03971266

Malignant Neoplasm

TERMINATED NA

Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation

NCT02844400

Malignant Solid Tumor Hematologic Malignancies

COMPLETED

Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer

NCT00603057

Non-Small Cell Lung Cancer

COMPLETED

Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting

NCT03804255

Breast Carcinoma Colorectal Carcinoma Community Practice +3 more

WITHDRAWN

STRENGTH Expansion

NCT04520867

Esophageal Cancer Gastroesophageal Junction Cancer

WITHDRAWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVE:

I. To determine the correlation between patient acceleration of the spine base/non-pivoting leg captured with in-office movement trackers, and physician/patient assessed Eastern Cooperative Oncology Group (ECOG) performance status (PS) using a Microsoft Kinect movement tracker.

SECONDARY OBJECTIVES:

I. To determine the correlation between clinician/patient assessed ECOG PS and Kinect assessed ECOG PS score.

II. To determine the range of measured patient acceleration measurements for each ECOG score between 0 and 3.

OUTLINE: This is an observational study.

Patients undergo "Get Up and Go" assessment as well as a chair-to-table assessment during the clinic visit on study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observational ("Get Up and Go" and chair-to-table assessments)

Patients undergo "Get Up and Go" assessment as well as a chair-to-table assessment during the clinic visit on study.

Functional Assessment

Intervention Type OTHER

Undergo chair-to-table assessment

Timed Get Up and Go Test

Intervention Type BEHAVIORAL

Undergo "Get Up and Go" assessment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Functional Assessment

Undergo chair-to-table assessment

Intervention Type OTHER

Timed Get Up and Go Test

Undergo "Get Up and Go" assessment

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A diagnosis of cancer
* Age \>= 18 years
* Ability to understand and the willingness to sign a written informed consent
* Able to ambulate without an assistive device

Exclusion Criteria

* Missing lower limbs
* Known movement disorder such as Parkinson's disease, choreoathetoid movement disorders, essential tremor if that movement disorder is of sufficient severity to require drug therapy

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No